We are live on ! Find out more
CWM

Cabot Wealth Management Portfolio holdings

AUM $982M
1-Year Est. Return 21.85%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+21.85%
3 Year Est. Return
+69.26%
5 Year Est. Return
+82.26%
10 Year Est. Return
+369.65%
AUM
$389M
AUM Growth
+$9.19M
Cap. Flow
-$5.91M
Cap. Flow %
-1.52%
Top 10 Hldgs %
25.15%
Holding
157
New
10
Increased
44
Reduced
77
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 13.47%
2 Financials 11.94%
3 Consumer Discretionary 10.9%
4 Technology 9.31%
5 Communication Services 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSD icon
151
Invesco S&P Spin-Off ETF
CSD
$221M
-57,156
Closed -$2.25M
NBB icon
152
Nuveen Taxable Municipal Income Fund
NBB
$447M
-8,875
Closed -$202K
PEP icon
153
PepsiCo
PEP
$190B
-2,048
Closed -$217K
SKX
154
DELISTED
Skechers
SKX
-107,320
Closed -$3.19M
SQQQ icon
155
ProShares UltraPro Short QQQ
SQQQ
$2.04B
-24
Closed -$4.38M
VEU icon
156
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
-50,301
Closed -$2.15M
ARMH
157
DELISTED
ARM HOLDINGS PLC ADS
ARMH
-63,946
Closed -$2.91M

Similar funds

Cabot Wealth Management's Q3 2016 Portfolio in Review

As of Q3 2016, Cabot Wealth Management held 157 positions worth $389M, up 2.4% from $380M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Cabot Wealth Management's Q3 2016 filing shows 10 new, 44 increased, 77 reduced and 8 closed positions. Its largest new stake was Ligand Pharmaceuticals: 81,375 shares worth $5.18M. The largest sale was ProShares UltraPro Short QQQ, an estimated $4.38M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cabot Wealth Management's largest Q3 2016 buy was Ligand Pharmaceuticals: 81,375 shares worth $5.18M.
  • Cabot Wealth Management added most to Salesforce in Q3 2016, an estimated $1.88M increase.
  • Cabot Wealth Management's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $3.66M.
  • Cabot Wealth Management fully exited ProShares UltraPro Short QQQ in Q3 2016, selling an estimated $4.38M.
  • Cabot Wealth Management's ten largest holdings make up 25% of its $389M portfolio in Q3 2016.
  • Cabot Wealth Management opened 10 new positions and closed 8 in Q3 2016.
  • Cabot Wealth Management's portfolio value rose 2.4% quarter-over-quarter to $389M.

Based on Cabot Wealth Management's 13F filing for Q3 2016, filed 8 Nov 2016.